{"id":20297,"date":"2022-01-25T14:56:10","date_gmt":"2022-01-25T13:56:10","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=20297"},"modified":"2022-01-25T14:56:13","modified_gmt":"2022-01-25T13:56:13","slug":"bd-pfizer-wellcome-collaborate-to-improve-global-hospital-antimicrobial-stewardship-practices","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/bd-pfizer-wellcome-collaborate-to-improve-global-hospital-antimicrobial-stewardship-practices\/","title":{"rendered":"BD, Pfizer, Wellcome Collaborate to Improve Global Hospital Antimicrobial Stewardship Practices"},"content":{"rendered":"\n

Article published on Cision PR Newswire<\/a> on January 11, 2022<\/p>\n\n\n\n

Joint Effort Will Highlight How Diagnostic Best Practices Can Improve Patient Care, Clinical Practice and Health Care Economics<\/p>\n\n\n\n

\n\n\n\n

FRANKLIN LAKES, BD (Becton, Dickinson and Company) (NYSE:\u00a0BDX<\/a>), a leading global medical technology company, today announced a collaboration with Pfizer Inc. and global charitable foundation Wellcome to better understand the role of diagnostics in advancing antimicrobial stewardship practices around the world.<\/p>\n\n\n\n

Building on ongoing efforts to advance the role of diagnostics in tackling the challenge of antimicrobial resistance (AMR), this collaboration will survey existing diagnostic practices to highlight both benefits and gaps in diagnostic testing in AMR stewardship to improve and further advocate for patient care, clinical practice and health care economics.<\/p>\n\n\n\n

“Diagnostic stewardship \u2014 meaning coordinated guidance and interventions to improve appropriate use of microbiological diagnostics to guide therapeutic decisions \u2014 promotes appropriate, timely diagnostic testing, including specimen collection and pathogen identification as well as accurate, timely reporting of results to guide patient treatment,” said Brooke Story, president of Integrated Diagnostic Solutions for BD. “Research shows us that significant barriers must be overcome to make health care workers aware of the importance and positive impact of diagnostics on AMR.” i<\/sup><\/p>\n\n\n\n

AMR occurs when bacteria, viruses, fungi or parasites change over time and no longer respond to medicines. These changes make infections harder to treat and increase the risk of disease transmission, severe illness and death. As the organisms that cause infections become increasingly drug resistant, even common medical procedures \u2014 including surgery, childbirth and chemotherapy \u2014 can become increasingly life-threatening.ii<\/sup>  A continued rise in AMR could take 10 million lives globally each year by 2050 \u2013 more than currently die from cancer.iii<\/sup><\/p>\n\n\n\n

The important role diagnostics can play as a tool to improve appropriate use of antibiotics is recognized by policymakers and advocates. AMR Review \u2014 an organization commissioned by the U.K. prime minister and chaired by Lord\u00a0Jim O’Neill\u00a0\u2014 includes promotion of “new rapid diagnostics to cut unnecessary use of antibiotics” as one of its 10 primary recommendations.iv<\/sup>\u00a0However, progress in implementing the AMR Review’s recommendations remains slow and diagnostics remain an under-utilized resource for optimizing antimicrobial (antibacterial, antifungal and antiviral) treatments and supporting antimicrobial stewardship efforts.\u00a0<\/p>\n\n\n\n

“Having the right diagnostic tools for the right contexts, and ensuring their uptake is crucial to fight antimicrobial resistance and save modern medicine,” said Dr. Gemma Buckland-Merrett, DRI Research Lead at Wellcome. “We need to preserve and sustain the efficacy and longevity of existing antimicrobials and protect the effectiveness of future drugs. This collaboration will help address the challenge and contribute to better outcomes for patients, clinical practice and health care.”<\/p>\n\n\n\n

The COVID-19 pandemic has put antimicrobial resistance into sharp focus, with early case studies and surveys of COVID-19 treatment pathways showing a high proportion of antibiotic use despite low risk of secondary bacterial infections in the majority of patients.v<\/sup> This early data prompted the World Health Organization (WHO) to issue a bulletin warning about the risk of the COVID-19 pandemic exacerbating the potential for AMR.vi<\/sup> The collaboration will help raise awareness of the critical role of diagnostics in combating AMR. <\/p>\n\n\n\n

“The incorrect use of antimicrobial medicines is a strong contributor to the growth of resistant microbes, and we need to employ antimicrobial stewardship practices as a way of slowing emergence to resistance and prolonging the usefulness of available treatments,” said Dr. Pol Vandenbroucke, chief medical officer, Hospital Business, Pfizer Inc. <\/p>\n\n\n\n

“This greater oversight requires a multifaceted approach spanning key diagnostics, improved education and innovative surveillance measures. As AMR continues to rise, we must all work together \u2014 across the biopharmaceutical and diagnostic industries, government and other important stakeholders \u2014 to invest in measures that will improve the diagnosis and treatment of patients around the world and contribute to our shared goal of slowing the spread of this deadly global public health threat.”<\/p>\n\n\n\n

About BD
<\/strong>BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. <\/p>\n\n\n\n

BD and its 75,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians’ care delivery process, enable laboratory scientists to accurately detect disease and advance researchers’ capabilities to develop the next generation of diagnostics and therapeutics. <\/p>\n\n\n\n

BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit\u00a0bd.com<\/a>\u00a0or connect with us on LinkedIn at\u00a0www.linkedin.com\/company\/bd1\/<\/a>\u00a0and Twitter\u00a0@BDandCo<\/a>.<\/p>\n\n\n\n

About Wellcome
<\/strong>Wellcome supports science to solve the urgent health challenges facing everyone. We support discovery research into life, health and wellbeing, and we’re taking on three worldwide health challenges:\u00a0mental health, infectious disease and climate. Learn more at wellcome.org.<\/p>\n\n\n\n

i<\/sup> https:\/\/cms.wellcome.org\/sites\/default\/files\/2020-11\/wellcome-global-response-amr-report.pdf<\/a>; assessed 11\/19\/2021
ii<\/sup> https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance<\/a>; assessed 12\/14\/2021
iii<\/sup> https:\/\/amr-review.org\/sites\/default\/files\/160525_Final%20paper_with%20cover.pdf<\/a>; assessed 12\/14\/2021
iv<\/sup> https:\/\/amr-review.org\/sites\/default\/files\/160518_Final%20paper_with%20cover.pdf<\/a>; assessed 11\/19\/2021
v<\/sup> https:\/\/www.nature.com\/articles\/s41564-020-0739-4<\/a>; assessed 11\/19\/2021
vi<\/sup> https:\/\/www.who.int\/bulletin\/volumes\/98\/7\/20-268573.pdf<\/a>; assessed 11\/19\/2021<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Article published on Cision PR Newswire on January 11, 2022 Joint Effort Will Highlight How Diagnostic Best Practices Can Improve Patient Care, Clinical Practice and Health Care Economics FRANKLIN LAKES, BD (Becton, Dickinson and Company) (NYSE:\u00a0BDX), a leading global medical technology company, today announced a collaboration with Pfizer Inc. and global charitable foundation Wellcome to […]<\/p>\n","protected":false},"author":139,"featured_media":20303,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[31],"tags":[],"acf":[],"yoast_head":"\nBD, Pfizer, Wellcome Collaborate to Improve Global Hospital Antimicrobial Stewardship Practices - French\u00a0National ANTIBIOTIC RESISTANCE Portal<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/bd-pfizer-wellcome-collaborate-to-improve-global-hospital-antimicrobial-stewardship-practices\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BD, Pfizer, Wellcome Collaborate to Improve Global Hospital Antimicrobial Stewardship Practices - French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/bd-pfizer-wellcome-collaborate-to-improve-global-hospital-antimicrobial-stewardship-practices\/\" \/>\n<meta property=\"og:site_name\" content=\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"article:published_time\" content=\"2022-01-25T13:56:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-01-25T13:56:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/01\/Diagnostic-tubes.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"461\" \/>\n\t<meta property=\"og:image:height\" content=\"453\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"\u00c9milie Noguez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u00c9milie Noguez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/bd-pfizer-wellcome-collaborate-to-improve-global-hospital-antimicrobial-stewardship-practices\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/bd-pfizer-wellcome-collaborate-to-improve-global-hospital-antimicrobial-stewardship-practices\/\"},\"author\":{\"name\":\"\u00c9milie Noguez\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\"},\"headline\":\"BD, Pfizer, Wellcome Collaborate to Improve Global Hospital Antimicrobial Stewardship Practices\",\"datePublished\":\"2022-01-25T13:56:10+00:00\",\"dateModified\":\"2022-01-25T13:56:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/bd-pfizer-wellcome-collaborate-to-improve-global-hospital-antimicrobial-stewardship-practices\/\"},\"wordCount\":947,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/bd-pfizer-wellcome-collaborate-to-improve-global-hospital-antimicrobial-stewardship-practices\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/01\/Diagnostic-tubes.jpg\",\"articleSection\":[\"Actualit\u00e9s\"],\"inLanguage\":\"en-GB\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/bd-pfizer-wellcome-collaborate-to-improve-global-hospital-antimicrobial-stewardship-practices\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/bd-pfizer-wellcome-collaborate-to-improve-global-hospital-antimicrobial-stewardship-practices\/\",\"name\":\"BD, Pfizer, Wellcome Collaborate to Improve Global Hospital Antimicrobial Stewardship Practices - French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/bd-pfizer-wellcome-collaborate-to-improve-global-hospital-antimicrobial-stewardship-practices\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/bd-pfizer-wellcome-collaborate-to-improve-global-hospital-antimicrobial-stewardship-practices\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/01\/Diagnostic-tubes.jpg\",\"datePublished\":\"2022-01-25T13:56:10+00:00\",\"dateModified\":\"2022-01-25T13:56:13+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/bd-pfizer-wellcome-collaborate-to-improve-global-hospital-antimicrobial-stewardship-practices\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/bd-pfizer-wellcome-collaborate-to-improve-global-hospital-antimicrobial-stewardship-practices\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/bd-pfizer-wellcome-collaborate-to-improve-global-hospital-antimicrobial-stewardship-practices\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/01\/Diagnostic-tubes.jpg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/01\/Diagnostic-tubes.jpg\",\"width\":461,\"height\":453,\"caption\":\"Cr\u00e9dit : Pixabay\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/bd-pfizer-wellcome-collaborate-to-improve-global-hospital-antimicrobial-stewardship-practices\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Practical info & communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"News\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"BD, Pfizer, Wellcome Collaborate to Improve Global Hospital Antimicrobial Stewardship Practices\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"name\":\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"description\":\"INSERM - From science to health\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\",\"name\":\"\u00c9milie Noguez\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BD, Pfizer, Wellcome Collaborate to Improve Global Hospital Antimicrobial Stewardship Practices - French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/bd-pfizer-wellcome-collaborate-to-improve-global-hospital-antimicrobial-stewardship-practices\/","og_locale":"en_GB","og_type":"article","og_title":"BD, Pfizer, Wellcome Collaborate to Improve Global Hospital Antimicrobial Stewardship Practices - French\u00a0National ANTIBIOTIC RESISTANCE Portal","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/bd-pfizer-wellcome-collaborate-to-improve-global-hospital-antimicrobial-stewardship-practices\/","og_site_name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","article_published_time":"2022-01-25T13:56:10+00:00","article_modified_time":"2022-01-25T13:56:13+00:00","og_image":[{"width":461,"height":453,"url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/01\/Diagnostic-tubes.jpg","type":"image\/jpeg"}],"author":"\u00c9milie Noguez","twitter_card":"summary_large_image","twitter_misc":{"Written by":"\u00c9milie Noguez","Estimated reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/bd-pfizer-wellcome-collaborate-to-improve-global-hospital-antimicrobial-stewardship-practices\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/bd-pfizer-wellcome-collaborate-to-improve-global-hospital-antimicrobial-stewardship-practices\/"},"author":{"name":"\u00c9milie Noguez","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3"},"headline":"BD, Pfizer, Wellcome Collaborate to Improve Global Hospital Antimicrobial Stewardship Practices","datePublished":"2022-01-25T13:56:10+00:00","dateModified":"2022-01-25T13:56:13+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/bd-pfizer-wellcome-collaborate-to-improve-global-hospital-antimicrobial-stewardship-practices\/"},"wordCount":947,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/bd-pfizer-wellcome-collaborate-to-improve-global-hospital-antimicrobial-stewardship-practices\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/01\/Diagnostic-tubes.jpg","articleSection":["Actualit\u00e9s"],"inLanguage":"en-GB"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/bd-pfizer-wellcome-collaborate-to-improve-global-hospital-antimicrobial-stewardship-practices\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/bd-pfizer-wellcome-collaborate-to-improve-global-hospital-antimicrobial-stewardship-practices\/","name":"BD, Pfizer, Wellcome Collaborate to Improve Global Hospital Antimicrobial Stewardship Practices - French\u00a0National ANTIBIOTIC RESISTANCE Portal","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/bd-pfizer-wellcome-collaborate-to-improve-global-hospital-antimicrobial-stewardship-practices\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/bd-pfizer-wellcome-collaborate-to-improve-global-hospital-antimicrobial-stewardship-practices\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/01\/Diagnostic-tubes.jpg","datePublished":"2022-01-25T13:56:10+00:00","dateModified":"2022-01-25T13:56:13+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/bd-pfizer-wellcome-collaborate-to-improve-global-hospital-antimicrobial-stewardship-practices\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/bd-pfizer-wellcome-collaborate-to-improve-global-hospital-antimicrobial-stewardship-practices\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/bd-pfizer-wellcome-collaborate-to-improve-global-hospital-antimicrobial-stewardship-practices\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/01\/Diagnostic-tubes.jpg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/01\/Diagnostic-tubes.jpg","width":461,"height":453,"caption":"Cr\u00e9dit : Pixabay"},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/bd-pfizer-wellcome-collaborate-to-improve-global-hospital-antimicrobial-stewardship-practices\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Practical info & communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/"},{"@type":"ListItem","position":3,"name":"News","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/"},{"@type":"ListItem","position":4,"name":"BD, Pfizer, Wellcome Collaborate to Improve Global Hospital Antimicrobial Stewardship Practices"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"INSERM - From science to health","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3","name":"\u00c9milie Noguez"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-16 00:18:34","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/20297"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/users\/139"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/comments?post=20297"}],"version-history":[{"count":5,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/20297\/revisions"}],"predecessor-version":[{"id":20311,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/20297\/revisions\/20311"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/media\/20303"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/media?parent=20297"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/categories?post=20297"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/tags?post=20297"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}